36 results
DEFR14A
QSI
Quantum-Si Incorporated - Ordinary Shares
29 Apr 24
Revised proxy
8:16pm
at Fortis Life Sciences from September 2020 until December 2022, where she was accountable for organic revenue contribution, annual growth targets
8-K
EX-99.1
ktlxj0j946 2ek
20 Dec 22
Quantum-Si Announces Commercial Availability of PlatinumTM, the World’s First
8:34am
8-K
EX-10.1
ix33o9 p4fuig3gq
4 Oct 22
Quantum-Si Appoints Jeff Hawkins as Chief Executive Officer
8:16am
424B3
rryv htc0fh
9 May 22
Prospectus supplement
4:24pm
424B3
cs295v9wodkv v7
9 May 22
Prospectus supplement
4:21pm
8-K
EX-10.1
t5enh
9 May 22
Quantum-Si Reports First Quarter 2022 Financial Results
4:18pm
DEF 14A
wndle
29 Mar 22
Definitive proxy
4:01pm
424B3
88nuipqzp
4 Mar 22
Prospectus supplement
4:02pm
POS AM
ivzoe
1 Mar 22
Prospectus update (post-effective amendment)
9:51pm
424B3
xyym472ca5
16 Aug 21
Prospectus supplement
5:20pm
424B3
sx0g ct5d5kn8
22 Jul 21
Prospectus supplement
6:02am
424B3
zy0kbcsd f2nxpj
14 May 21
Prospectus supplement
4:16pm